TX-GRC
13.2.2020 15:07:11 CET | Business Wire | Press release
GRC (Green Revolution Cooling), the leader in single-phase immersion cooling for data centers , today announced a new business collaboration with HiTeam, a subsidiary of E-Smart Systems, at the new ZELENDATA CENTRE in Technology Park in Vršac, Serbia, the country’s first green data center.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005508/en/
ZELENDATA CENTRE provides colocation, infrastructure as a service, and software as a service, and its Supermicro® servers are being cooled by GRC’s ICEraQ™ liquid immersion cooling systems.
“Our goal is to provide infrastructure with lower operating costs, as well as being environmentally conscious,” said Goran Veljović, Sales and Marketing Director at E-Smart Systems. “Using the ICEraQ immersion cooling system provides critical services today and will meet the needs of future data center users, while enabling companies to be environmentally responsible in their choice of data center provider. As the first green data center in Serbia, we are excited for the ZELENDATA CENTRE to lead the way, enabling Serbians to embrace business performance using green technologies.”
One of the main motivators for using GRC liquid-immersion cooling was the need to protect the environment in a cost-effective way. Additionally, the data center will realize a lower initial cost, as well as a significant savings in the Total Cost of Ownership (TCO), when compared to a traditional air-cooled data center. The main source of electricity for the data center is the MK Fintel Winds’ Košava wind farm in Izbiste. GRC’s immersion-cooling solution reduces electricity consumption of the cooling system at ZELENDATA CENTRE by 90%, or approximately 40% of the total consumption of the data center.
"We are thrilled to partner with E-Smart Systems to offer our ICEraQ Quad immersion cooling systems to the southeastern Europe market,” said Peter Poulin, CEO at GRC. “They are dedicated to protecting the environment, using green ‘environmentally friendly’ solutions for their data centers, and that aligns with one of our core values here at GRC. It is an honor to be here with the U.S. Ambassador, the Honorable Anthony F. Godfrey to recognize E-Smart Systems and the ZELENDATA CENTRE for their focus on the environment and goal to provide mission critical services to organizations here in Serbia.”
About the ZELENDATA CENTRE
- 400m2 space
- 12 ICEraQ Quads. Each Quad includes 4 ICEraQ systems at 25kw per rack.
- Up to 2 MW substation
- Uses a Dry Cooler
- Modular UPS system
- BISCI and AISI standards
On Wednesday, Peter Poulin attended the ZELENDATA CENTRE grand opening ceremony, along with the Honorable Anthony F. Godfrey, U.S. Ambassador to Serbia; Goran Trivan, Serbia Minister of Environmental Protection; Dragana Mirovic, Mayor of Vršac, Serbia; Goran Veljović, Sales and Marketing Director at E-Smart Systems and 150+ additional stakeholders.
About GRC
GRC is the immersion cooling authority™. The company's patented immersion-cooling technology radically simplifies deployment of data center cooling infrastructure. By eliminating the need for chillers, CRACs, air handlers, humidity controls and other conventional cooling components, enterprises reduce their data center design, build, energy, and maintenance costs. GRC’s solutions are deployed in seventeen countries and are ideal for next-gen applications platforms, including artificial intelligence, blockchain, HPC, 5G, and other Edge Computing and core applications. Their systems are environmentally resilient, sustainable, and space saving, making it possible to deploy the solution in virtually any location with minimal lead time. Visit http://grcooling.com for more information.
About HiTeam
HiTeam was founded in 2003 as part of Hemofarm a.d. The company was the first to bring internet access to Vršac through dial-up and wireless connection, as well as the first internet café in the city. Today the company is 100% owned by E-Smart Systems from Belgrade, with over 90 employees and is the undisputed leader in the regional IT market. Their portfolio of products includes Internet service provider, system support, retail and wholesale hardware and software, and installation of cable systems.
About E-Smart Systems
E-Smart Systems d.o.o. Beograd was founded in 2000 in Belgrade. It is a privately-owned company engaged in development, production, design, implementation and education in the field of information technology. Since 2011, the company has been certified ISO 9001, ISO 27001, and ISO 20000. As one of the first companies in the region using cloud computing, the company offers numerous services to its clients, including information systems safety, financial and industrial systems, IT infrastructure and protection, development and implementation of Microsoft Share Point platform-based solutions, mobile technologies, mobile gateway and embedded systems.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200213005508/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom